ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,582Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 120

$606K Total Retail Price of All Prescriptions

Rank: 20 out of 120

688 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Montana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 688 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 688 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 649 555 148 1 1
SIMVASTATIN 462 420 123 2 2
LISINOPRIL 367 308 92 3 3
AMLODIPINE BESYLATE 318 299 78 4 5
OMEPRAZOLE 294 243 75 5 4
LOSARTAN POTASSIUM 274 259 64 6 11
HYDROCODONE-ACETAMINOPHEN 255 223 65 S3 7 7
WARFARIN SODIUM 218 188 46 8 8
FUROSEMIDE 214 182 59 9 6
HYDROCHLOROTHIAZIDE 213 191 62 10 10
POTASSIUM CHLORIDE 204 181 54 11 12
METOPROLOL SUCCINATE 198 181 48 12 13
CITALOPRAM HBR 192 170 57 13 17
METFORMIN HCL ER 163 128 40 14 59
GABAPENTIN 143 124 34 15 16
ZOLPIDEM TARTRATE 139 121 35 16 22
FLUOXETINE HCL 127 111 26 17 35
ATORVASTATIN CALCIUM 117 112* 33 18 9
LORAZEPAM 117 105 37 B 18 21
TRAMADOL HCL 114 72 37 20 26
TRAZODONE HCL 114 74 21 20 37
PRAVASTATIN SODIUM 111 92 32 22 23
ATENOLOL 107 95 33 23 18
SERTRALINE HCL 103 66 27 24 20
FLUTICASONE PROPIONATE 100 95* 46 25 36
ALLOPURINOL 96 71 16 26 19
TRIAMTERENE-HCTZ 93 88* 25 27 29
METOPROLOL TARTRATE 93 78 24 27 15
ALENDRONATE SODIUM 92 87* 23 29 27
VENLAFAXINE HCL ER 88 77 14 30 53
PREMARIN 88 83* 21 R 30 89
DIOVAN 88 88 22 30 49
CLOPIDOGREL 84 79* 19 33 28
ADVAIR DISKUS 76 76 22 34 31
PAROXETINE HCL 73 68* 17 35 55
METFORMIN HCL 72 67* 22 36 14
IRBESARTAN 71 66* 15 37 69
MONTELUKAST SODIUM 67 41 13 38 65
CYCLOBENZAPRINE HCL 66 61* 16 R 39 94
OXYBUTYNIN CHLORIDE 66 61* 19 39 88
ESCITALOPRAM OXALATE 63 58* 12 41 54
MELOXICAM 61 56* 16 42 44
CRESTOR 60 55* 11 43 32
ALPRAZOLAM 58 38 16 B 44 46
CLONAZEPAM 58 53* 20 B 44 42
GLIPIZIDE ER 57 52* 12 46 105
DIGOX 57 52* 11 46 57
DONEPEZIL HCL 57 57 12 46 39
NEXIUM 57 31 15 46 52
LYRICA 56 51* 12 50 78
AMITRIPTYLINE HCL 54 49* 15 R 51 66
VERAPAMIL ER 53 31 12 52 121
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.